Management of Iron Deficiency Anemia with Heavy Menstrual Bleeding in a Young Woman
This 20-year-old woman requires immediate iron replacement therapy (oral or IV depending on severity), evaluation for an underlying bleeding disorder, and gynecologic management of her heavy menstrual bleeding—GI endoscopy is NOT indicated given her clear menstrual etiology.
Initial Diagnostic Evaluation
Laboratory Assessment
- Measure ferritin level immediately to confirm iron deficiency (threshold <45 μg/L per AGA guidelines, though <30 μg/L is more specific) 1
- Check complete blood count with hemoglobin and mean corpuscular volume
- Critical caveat: Nearly half of iron-deficient young women with HMB have normal hemoglobin—screening with CBC alone misses 50-60% of cases 2
- Obtain transferrin saturation if ferritin is borderline or inflammatory conditions suspected 1
Bleeding Disorder Screening
This is essential and commonly missed. Heavy menstrual bleeding in adolescents is a hallmark presentation of underlying bleeding disorders 3. Evaluate for:
- Von Willebrand disease (most common—can present as chronic iron deficiency with menorrhagia) 4
- Platelet function disorders
- Other coagulation abnormalities
- Refer to hematology for formal bleeding disorder workup 5, 3
Menstrual History Documentation
Document specific details (only 46-72% of providers do this adequately) 6:
- Duration of menses (her 6 days is normal)
- Number of heavy flow days (her 2 days qualifies as HMB)
- Pad/tampon changes per hour on heavy days
- Presence of clots
- Impact on daily activities (her exercise-induced symptoms suggest significant anemia)
When to Avoid GI Endoscopy
Do NOT pursue bidirectional endoscopy in this patient. The AGA guideline explicitly states that endoscopy is conditional in premenopausal women and should be avoided when there is "another unequivocal explanation for IDA, particularly in younger women" 7. Her heavy menstrual bleeding provides this clear explanation.
Key points from the guideline 7:
- GI malignancy risk in premenopausal women: 0.9% for lower GI, 0.2% for upper GI (likely overestimates)
- Risk decreases substantially with younger age
- Patients who are young with plausible menstrual causes should receive iron replacement without initial endoscopy
- No GI symptoms are reported in this case
Iron Replacement Strategy
Oral Iron (First-Line for Mild-Moderate Anemia)
- Ferrous sulfate, ferrous fumarate, or ferrous gluconate are reasonable first choices (least expensive) 1
- Dosing: Take on empty stomach when possible for better absorption
- Add 500 mg vitamin C to enhance absorption 1
- Taking with meat protein improves absorption 1
- If GI side effects occur, consider ferrous bisglycinate or taking with meals (though absorption decreases)
Intravenous Iron (Consider if):
- Severe anemia (hemoglobin <7-8 g/dL based on symptoms)
- Failed oral iron trial
- Intolerance to oral iron
- Need for rapid repletion 1, 5
Her tunnel vision and dizziness with exercise suggest symptomatic anemia requiring aggressive treatment—consider IV iron if hemoglobin is significantly low 8.
Follow-Up Monitoring
- Recheck hemoglobin in 4-6 weeks after starting oral iron
- Recheck ferritin after 8-12 weeks
- Major gap in practice: Only 15% of patients receive appropriate follow-up testing 9
Gynecologic Management
Hormonal Therapy for Heavy Menstrual Bleeding
- Combined oral contraceptives are first-line for menstrual regulation 8
- Reduces menstrual blood loss and prevents recurrent iron deficiency
- Should be initiated concurrently with iron replacement
Common Pitfall
10% of adolescents with HMB and severe anemia receive no hormonal therapy during initial management—this is inadequate 8.
Addressing Exercise-Induced Symptoms
Her tunnel vision and dizziness with vigorous exercise indicate:
- Symptomatic anemia requiring urgent treatment
- Need for activity modification until hemoglobin improves
- Strong association between HMB, iron deficiency, and exercise intolerance in active females 10
Key Clinical Pitfalls to Avoid
- Don't screen with hemoglobin alone—misses >50% of iron deficiency 2
- Don't pursue GI workup when HMB clearly explains the anemia 7
- Don't forget bleeding disorder evaluation—this is underdiagnosed and causes diagnostic delays with significant morbidity 3
- Don't fail to treat the HMB itself—iron replacement alone without menstrual management leads to recurrence 8
- Don't skip follow-up testing—only 15% receive appropriate monitoring 9
Multidisciplinary Coordination
Consider involving:
- Gynecology for HMB management
- Hematology for bleeding disorder workup and complex anemia management 1, 3
- Nutrition consultation to optimize dietary iron intake 1
The evidence strongly supports that young women with HMB and iron deficiency are systematically underdiagnosed and undertreated 11. This patient requires comprehensive management addressing both iron repletion and the underlying menstrual cause, with appropriate screening for bleeding disorders that may have lifelong implications for her and family members 3.